Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia
Clinical trial NCT03620903 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03620903
- Sponsor
- Christian Buske
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-11
- Primary completion
- 2022-11-14
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.